ClinConnect ClinConnect Logo
Search / Trial NCT04280978

Pragmatic Abilities in Children With Acquired Brain Injury

Launched by IRCCS EUGENIO MEDEA · Feb 20, 2020

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

**Summary of the Clinical Trial: Pragmatic Abilities in Children With Acquired Brain Injury**

This clinical trial is investigating how children with acquired brain injuries (ABI) communicate in everyday situations. Children with ABI, including those who have had traumatic brain injuries or brain tumors, often face challenges in pragmatic communication, which means understanding and using language appropriately in social contexts. Unfortunately, current tests may not fully capture these communication difficulties because they tend to focus only on understanding language rather than how children use it in real-life conversations. To address this gap, researchers have developed a new assessment tool called "ABaCo," which is designed to evaluate all aspects of pragmatic communication. This study aims to see if the ABaCo test can effectively identify communication challenges in children aged 6 to 11 who have experienced ABI.

To participate in this trial, children must be Italian, between 6 and 11 years old, and at least six months post-injury. They should not have other communication disorders like aphasia (difficulty speaking) or sensory issues. Families who join the study can expect their child to take the ABaCo test, which involves watching short videos and responding to various communication scenarios. This research is essential because it could lead to better assessments and treatments for children facing communication challenges after brain injuries, ultimately helping them improve their social interactions and quality of life.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • italian
  • 6 to 11 years old
  • at least 6 months after ABI onset
  • Exclusion Criteria:
  • diagnosis of aphasia, dysarthria, apraxia, and/or sensorial difficulties (visual and hearing)

About Irccs Eugenio Medea

IRCCS Eugenio Medea is a leading clinical research institute based in Italy, dedicated to advancing pediatric healthcare through innovative research and evidence-based practices. As a recognized center of excellence, it focuses on multidisciplinary approaches to address complex health challenges in children and adolescents, particularly in the fields of neurodevelopmental disorders, mental health, and rehabilitation. The institute collaborates with national and international partners to conduct rigorous clinical trials, aiming to translate scientific discoveries into effective therapeutic interventions. Committed to enhancing patient outcomes, IRCCS Eugenio Medea prioritizes ethical standards and patient safety in all its research endeavors.

Locations

Bosisio Parini, Lecco, Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials